GlassScriptPhysician profile
Sylvonne Cox
NPI 1992863385
$9,620.38
in general payments reported to CMS, 2019-2025
44 companies · $2,531 in 2025
The $2,531 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $757 · 2022: $1,227 · 2023: $2,570 · 2024: $2,535 · 2025: $2,531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,367 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,367.23 |
| Education | $268.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,342.06 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,103.19 | 2021-2025 | Ofev, Jascayd, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $943.14 | 2021-2025 | Tezspire, Airsupra, Fasenra |
| Genzyme Corporation | $901.20 | 2021-2025 | |
| Grifols USA, LLC | $466.92 | 2022-2025 | Prolastin-C Liquid, Xembify |
| Amgen INC. | $446.51 | 2022-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $405.28 | 2022-2025 | Dupixent |
| Harmony Biosciences LLC | $389.28 | 2023-2025 | Wakix |
| Ani Pharmaceuticals, INC. | $354.78 | 2023-2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $335.32 | 2021-2025 | Acthar |
| Jazz Pharmaceuticals INC. | $332.40 | 2021-2025 | Xywav |
| Baxter Healthcare | $319.59 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $271.95 | 2021-2025 | Opsumit, Uptravi |
| Insmed, INC. | $268.75 | 2021-2025 | Brinsupri, Arikayce |
| Verona Pharma, INC. | $206.55 | 2025 | Ohtuvayre |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $184.93 | 2021-2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $105.84 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $105.39 | 2021-2023 | |
| Axsome Therapeutics, INC. | $103.22 | 2024-2025 | Sunosi |
| Pulmonx Corporation | $95.97 | 2023-2025 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Csl Behring | $79.39 | 2022-2023 | Hizentra |
| Merck Sharp & Dohme LLC | $76.15 | 2022-2024 | Winrevair |
| 3b Medical, INC. | $72.80 | 2024-2025 | Luna |
| Gilead Sciences, INC. | $70.42 | 2021-2023 | |
| Viatris Specialty LLC | $69.23 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $52.60 | 2021-2023 | Cinqair |
| Avadel Cns Pharmaceuticals, LLC | $52.43 | 2024-2025 | Lumryz |
| Lilly USA, LLC | $42.44 | 2025 | Zepbound |
| Inogen, INC. | $41.91 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| United Therapeutics Corporation | $40.12 | 2021-2023 | Tyvaso |
| Novartis Pharmaceuticals Corporation | $40.04 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $33.44 | 2022-2023 | Ultomiris |
| Tactile Systems Technology INC | $30.78 | 2024 | Entre Plus, Flexitouch Plus |
| Philips North America LLC | $29.95 | 2022 | |
| Inspire Medical Systems, INC. | $29.11 | 2025 | Inspire |
| Abbvie INC. | $28.50 | 2023 | |
| Stryker Corporation | $22.19 | 2025 | Flowtriever |
| La Jolla Pharmaceutical Company | $21.02 | 2025 | Giapreza |
| Takeda Pharmaceuticals U.S.A., INC. | $20.12 | 2022 | |
| Bard Peripheral Vascular, INC. | $18.95 | 2023 | |
| Advanced Respiratory, INC | $16.79 | 2021 | |
| Pfizer INC. | $16.75 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.64 | 2021 | |
| Olympus America INC. | $16.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvonne Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.